Business Wire
-
WMI Partners With Arcadea Group
8/26/2025
Arcadea Group, a preeminent, long-term investor in global software businesses, today announced its acquisition of WMI, a leading provider of laboratory information management solutions in Brazil through its flagship Autolac software suite.
-
Thermo Fisher Scientific Opens Manufacturing Center Of Excellence Site In North Carolina
8/21/2025
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the grand opening of its innovative manufacturing center of excellence facility in Mebane, N.C.
-
Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit
8/21/2025
Quanterix Corporation, a company fueling scientific discovery through ultrasensitive biomarker detection, today announced the New York State Department of Health (NYSDOH) has granted the Quanterix Accelerator Laboratory a clinical laboratory permit in the Clinical Chemistry category.
-
Agilent MMR IHC Panel pharmDx (Dako Omnis) Receives FDA Approval As A Companion Diagnostic Test For Colorectal Cancer
8/20/2025
Agilent Technologies Inc. today announced that its MMR IHC Panel pharmDx (Dako Omnis) has received FDA approval as a companion diagnostic (CDx) test for colorectal cancer.
-
Twist Bioscience Launches Oncology DNA CGP Panel To Advance Precision Medicine With Customizable, Platform-Agnostic NGS Solution
8/19/2025
Twist Bioscience Corporation, a core mid-cap growth and value equity, in the life sciences segment of the health care sector, today launched the Twist Oncology DNA Comprehensive Genomic Profiling (CGP) Panel, a customizable, research-use-only solution designed to empower users to identify genomic alterations for a broad set of tumors, guide targeted therapy development and support clinical and translational oncology research.
-
Seek Labs Unveils Investigational, Equipment-Free Molecular Prototype For MTB On Rapid-Deploy SeekIt Platform
8/13/2025
Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced a significant advancement in the global fight against tuberculosis (TB) with an investigational prototype for Mycobacterium tuberculosis (MTB) detection on its SeekIt platform.
-
Techcyte And Modella AI Announce A Research Collaboration With Modella AI's State-Of-The-Art Agentic And Generative AI-Powered Diagnostic Pathology Platform
8/12/2025
Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced that its platform, Techcyte Fusion (research use only (RUO) in the US, CE-IVDD-marked in Europe), now includes Modella AI, a biomedical artificial intelligence company at the forefront of computational pathology, as a partner in the Techcyte Fusion Partner Program.
-
Thermo Fisher Receives FDA Approval For NGS-Based Companion Diagnostic For New Non-Small Cell Lung Cancer Treatment
8/11/2025
Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Oncomine Dx Target Test as a companion diagnostic (CDx) to identify patients who may be candidates for HERNEXEOS (zongertinib tablets), a tyrosine kinase inhibitor (TKI), developed by Boehringer Ingelheim.
-
C2N Announces Major Global Expansion, Adds Six New International Partners
8/7/2025
C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation, is reaching additional global healthcare providers eager to use its PrecivityAD2 blood test to help diagnose Alzheimer’s disease.
-
Pleno Inc. Announces First Commercial Agreement With Slopes Bio, Inc
8/6/2025
Pleno Inc., an early-stage biotechnology company developing innovative multi-omic solutions, and Slopes Bio, Inc., an innovative high-complexity accredited laboratory, today announced a comprehensive commercial agreement in biological target detection and personalized health.